inflammatory-bowel-disease

Documents about inflammatory-bowel-disease

• Pathogenesis of Intestinal Behcet's Syndrome#858992ClinicalTrials.gov
• Pediatric GI Endoscopy at Assiut University#910249ClinicalTrials.gov
• Reproductive Health in Young and Adolescent Females with Inflammatory Bowel Disease#1065616Europe PMC
• Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)#850079ClinicalTrials.gov
• Deciphering immune and cellular reprogramming during the progression from inflammatory bowel disease to colorectal cancer using multi-omics single-cell and spatial transcriptomics.#143204NCBI PubMed Central
• Supplementary Material for: A case report of an asymptomatic cecum ulceration colonoscopically and radiologically mimicking inflammatory bowel disease caused by amoebic colitis#226652Figshare
• Caregiver contribution to patient self‑care and quality of life among informal carers of adult patients with inflammatory bowel disease: a cross‑sectional study.#284893NCBI PubMed Central
• Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay Diet is Associated with Reduced Inflammatory Bowel Disease Related Surgery Risk: A Prospective Cohort Study#319795bioRxiv / medRxiv
• RNA-seq gene expression count data for: Multidimensional Mucosal Transcriptomic Variation at Diagnosis in Colonic Inflammatory Bowel Disease#336835api.researchdata.se
• Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial.#340322NCBI PubMed Central
• Effects of Anacyclus pyrethrum L on a mouse model of inflammatory bowel disease and its influence on intestinal barrier function and gut microbiota.#412318NCBI PubMed Central
• LIAISON ® Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study#983953HAL (France)
• Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products#905117ClinicalTrials.gov
• Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease#802040ClinicalTrials.gov
• The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery#847153ClinicalTrials.gov
• Human Gut Commensal <i>Alistipes Timonensis</i> Modulates the Host Lipidome and Delivers Anti-Inflammatory Outer Membrane Vesicles to Suppress Colitis in an <i>Il10</i>-Deficient Mouse Model#339107Scholar Commons
• The chain mediating roles of stigma and health-promoting lifestyle in the relationship between disability index and posttraumatic growth among patients with inflammatory bowel disease.#402488NCBI PubMed Central
• Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results#643353HAL (France)
• An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice#967503ClinicalTrials.gov
• Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study#983947HAL (France)
• A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).#1030312ClinicalTrials.gov
• Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications#1033017ClinicalTrials.gov
• Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility#859744ClinicalTrials.gov
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis#982700ClinicalTrials.gov
• IBD Biomarker Discovery and Validation Platform#969561ClinicalTrials.gov
• Regulation of IkBz by NADPH Oxidase 1 in colon epithelial cells and its impact in intestinal inflammation#330053HAL (France)
• Reduced Intestinal GLP-1+ Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature#357394HAL (France)
• Replication Data for: Cardiorespiratory Fitness, Muscular Strength and Physical Activity in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis#367025e-cienciaDatos Dataverse OAI Archive
• T cell-specific knockout of STAT3 ameliorates dextran sulfate sodium-induced colitis by reducing the inflammatory response#389960S-Space: Seoul National University
• Patient Empowerment Among Children and Adolescents with Inflammatory Bowel Disease (IBD) and Parents of IBD Patients -Use of Counseling Services and Lack of Knowledge About Transition#395570JLUpub
• End User Needs and Perspectives for a Digital Opioid Safety Tool in Adolescents and Young Adults With Inflammatory Bowel Disease: A Qualitative Human-Centered Design Study.#420880NCBI PubMed Central
• Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota#785306Kyoto University Research Information Repository
• Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota#785337Kyoto University Research Information Repository
• Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)#886532ClinicalTrials.gov
• A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease#835171ClinicalTrials.gov
• Additional file 1 of Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis#318799Figshare
• Dietary Intake of Micro- and Nanoplastics: Potential Adverse GI Effects on Microbiome, Inflammation, and Neoplasia#351834ODU Digital Commons
• Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis#849933ClinicalTrials.gov
• Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients#892516ClinicalTrials.gov
• Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis#899065ClinicalTrials.gov
• An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study#898296ClinicalTrials.gov
• Could molecular variations be predictive in right and left colon cancer in different gender and age groups?#358730PLOS
• Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy#624873HAL (France)
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)#810317ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis#835273ClinicalTrials.gov
• Body Composition Assessment and Monitoring in Inflammatory Bowel Disease#891575ClinicalTrials.gov
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions#152605ClinicalTrials.gov
• Unraveling the drug resistance web in IBD: The gut microbiota-immunity-epigenetics axis#684623Europe PMC
• Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD#877925ClinicalTrials.gov
• The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD#845780ClinicalTrials.gov